BrightSpring Health Services CEO Sells $9.05M in Stock, Exercises Options
Summary
BrightSpring Health Services' CEO, Jon B. Rousseau, sold $9.05 million in common stock as part of a secondary offering, while also exercising options and receiving new equity grants.
Key Events
-
CEO Sells $9.05 Million in Stock
Jon B. Rousseau, Chairman, President, and CEO, disposed of 220,000 shares of common stock for $9,053,000 at a price of $41.15 per share on March 4, 2026. This sale was part of a registered public offering.
-
Exercises Options Valued at $1.4 Million
Concurrently with the sale, Mr. Rousseau exercised options to acquire 220,000 shares of common stock for $1,401,400 at an exercise price of $6.37 per share.
-
Receives New Equity Grants
The CEO also received grants of 1,600,676 shares of common stock and stock options on March 4-5, 2026, as part of his compensation.
Analysis
This Form 4 filing details significant insider activity from BrightSpring Health Services' CEO, Jon B. Rousseau. The primary market-moving event is the sale of $9.05 million in common stock, which occurred as part of the previously announced secondary offering that closed on March 4, 2026. While the overall offering was known, this filing provides specific insight into the CEO's participation and reduction in direct holdings. Concurrently, Mr. Rousseau exercised options valued at $1.4 million and received new equity grants, which are part of his compensation package. The substantial open market sale by the CEO, even within a broader offering, can be interpreted negatively as it reduces his direct ownership.
At the time of this filing, BTSG was trading at $41.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8B. The 52-week trading range was $15.48 to $44.87. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.